Correlating neighborhood‐level deprivation and pediatric metabolic dysfunction‐associated steatotic liver disease
Nicole E. Hickman, Mason Price, Noe C. Crespo, Ariel E. Feldstein- Gastroenterology
- Pediatrics, Perinatology and Child Health
Abstract
Objectives
The primary objective of this study is to further explore associations between social influencers of health and markers of disease severity at the time of presentation of patients with pediatric metabolic dysfunction‐associated steatotic liver disease (MASLD) using neighborhood‐level Area Deprivation Index (ADI) scores.
Methods
A retrospective cross‐sectional study was conducted among 344 pediatric MASLD patients. Each patient received an ADI score based on their 9‐digit zip code. Groups were defined as low (≤5) and high (6≥) ADI. Associations between ADI and symptomatology and laboratory values at presentation, as well as initial liver biopsy pathology were tested via analyses of covariance, χ2 testing, and logistic regressions.
Results
The mean ADI was 6.54 (SD = 2.09). ADI groups did not significantly differ in age of presentation, type of presentation, or associated conditions, except for the higher ADI group having on average lower vitamin D levels (26.70 vs. 29.91, p = 0.02) and being two times more likely to also be diagnosed with low HDL levels (p = 0.04, 95% CI 1.04–3.89). Mean transaminases and histopathologic nonalcoholic fatty liver disease (NAFLD) Activity Scores did not significantly differ between ADI groups.
Conclusions
Pediatric patients with MASLD in this study span the entire spectrum of neighborhood deprivation. There were no differences in presentation characteristics or severity of MASLD, aside from lower HDL‐cholesterol and vitamin D values in the high ADI group. Area deprivation was not predictive of more severe disease as assessed by serum transaminases and liver biopsy NAFLD activity scores.